"NINLIB" belongs to Tyrosine Kinase Inhibitor therapy of Oncology Division and it is available in 2 forms : Ninlib Capsules 150 mg and Ninlib Capsules 200 mg.
Copyright ©2025 All Rights Reserved by Hetero Healthcare Limited.